OBJECTIVE: There is increased interest in measuring peripheral oxytocin levels to better understand the role of this peptide in mammalian behavior, physiology, and disease. The purpose of this study was to compare methods for plasma oxytocin measurement using a commercially available enzyme immunoassay (EIA) and radioimmunoassay (RIA), to evaluate the need for sample extraction, and to assess the immunospecificity of the assays. METHODS: Oxytocin was measured in extracted and unextracted human plasma samples (n = 39). Oxytocin and its degradation products were separated by high-performance liquid chromatography and gel filtration chromatography and then assayed by EIA or RIA to identify oxytocin immunoreactive peaks. RESULTS: Without extraction, plasma measured by EIA was more than 100-fold higher than in extracted plasma, and the correlation between oxytocin levels in extracted and unextracted plasma was minimal (Spearman ρ = -0.10, p = .54). Using the RIA, most samples (>90%) were below the level of detection with or without extraction. After chromatographic fractionation of sample extracts, multiple immunoreactive products were found to be present in addition to oxytocin, which casts doubts on the specificity of the assays. CONCLUSIONS: Changes in oxytocin levels have been reported in social and behavioral challenge studies. This study indicates that sample extraction is necessary to obtain valid assay results. Changes in oxytocin degradation products are likely to contribute to the previously observed responses in circulating oxytocin levels to behavioral and social challenge. There is a critical need for valid and reliable methods to measure oxytocin in biologic samples.
OBJECTIVE: There is increased interest in measuring peripheral oxytocin levels to better understand the role of this peptide in mammalian behavior, physiology, and disease. The purpose of this study was to compare methods for plasma oxytocin measurement using a commercially available enzyme immunoassay (EIA) and radioimmunoassay (RIA), to evaluate the need for sample extraction, and to assess the immunospecificity of the assays. METHODS:Oxytocin was measured in extracted and unextracted human plasma samples (n = 39). Oxytocin and its degradation products were separated by high-performance liquid chromatography and gel filtration chromatography and then assayed by EIA or RIA to identify oxytocin immunoreactive peaks. RESULTS: Without extraction, plasma measured by EIA was more than 100-fold higher than in extracted plasma, and the correlation between oxytocin levels in extracted and unextracted plasma was minimal (Spearman ρ = -0.10, p = .54). Using the RIA, most samples (>90%) were below the level of detection with or without extraction. After chromatographic fractionation of sample extracts, multiple immunoreactive products were found to be present in addition to oxytocin, which casts doubts on the specificity of the assays. CONCLUSIONS: Changes in oxytocin levels have been reported in social and behavioral challenge studies. This study indicates that sample extraction is necessary to obtain valid assay results. Changes in oxytocin degradation products are likely to contribute to the previously observed responses in circulating oxytocin levels to behavioral and social challenge. There is a critical need for valid and reliable methods to measure oxytocin in biologic samples.
Authors: Kim Wolff; E M Tsapakis; A R Winstock; D Hartley; D Holt; M L Forsling; Katherine J Aitchison Journal: J Psychopharmacol Date: 2006-05 Impact factor: 4.153
Authors: Gregor Domes; Alexander Lischke; Christoph Berger; Annette Grossmann; Karlheinz Hauenstein; Markus Heinrichs; Sabine C Herpertz Journal: Psychoneuroendocrinology Date: 2010-01 Impact factor: 4.905
Authors: Timothy W Smith; Bert N Uchino; Justin MacKenzie; Angela M Hicks; Rebecca A Campo; Maija Reblin; Karen M Grewen; Janet A Amico; Kathleen C Light Journal: Int J Psychophysiol Date: 2012-04-26 Impact factor: 2.997
Authors: Austin Leeds; Patricia M Dennis; Kristen E Lukas; Tara S Stoinski; Mark A Willis; Mandi W Schook Journal: Primates Date: 2018-07-20 Impact factor: 2.163
Authors: Lucas G Speck; Johanna Schöner; Felix Bermpohl; Andreas Heinz; Jürgen Gallinat; Tomislav Majic; Christiane Montag Journal: Soc Cogn Affect Neurosci Date: 2019-01-04 Impact factor: 3.436
Authors: Suena H Massey; Stephanie A Schuette; Hossein Pournajafi-Nazarloo; Katherine L Wisner; C Sue Carter Journal: Arch Womens Ment Health Date: 2016-03-08 Impact factor: 3.633
Authors: Benjamin A Tabak; Suzanne Vrshek-Schallhorn; Richard E Zinbarg; Jason M Prenoveau; Susan Mineka; Eva E Redei; Emma K Adam; Michelle G Craske Journal: Clin Psychol Sci Date: 2015-05-13
Authors: David J Allsop; Delwyn J Bartlett; Jennifer Johnston; David Helliwell; Adam Winstock; Iain S McGregor; Nicholas Lintzeris Journal: J Clin Sleep Med Date: 2015-10-15 Impact factor: 4.062